S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
OTCMKTS:LZAGY

Lonza Group (LZAGY) Stock Forecast, Price & News

$46.69
-0.16 (-0.34%)
(As of 09/22/2023 ET)
Compare
Today's Range
$46.65
▼
$47.05
50-Day Range
$46.69
▼
$64.27
52-Week Range
$43.85
▼
$66.00
Volume
165,641 shs
Average Volume
75,347 shs
Market Capitalization
$34.77 billion
P/E Ratio
N/A
Dividend Yield
0.19%
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort Interest

Lonza Group MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.32mentions of Lonza Group in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
30.99%
From $1.42 to $1.86 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.57 out of 5 stars

See Top Rated MarketRank™ Stocks Here

LZAGY stock logo

About Lonza Group (OTCMKTS:LZAGY) Stock

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. It supports customers across various aspects of design, development, and manufacturing. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. In addition, this segment provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. The company was incorporated in 1897 and is headquartered in Basel, Switzerland.

LZAGY Price History

LZAGY Stock News Headlines

September 19, 2023 | finance.yahoo.com
UPDATE 2-Moderna to cut mRNA drug substance production at Lonza facility
September 18, 2023 | finance.yahoo.com
UPDATE 2-Swiss drug ingredient maker Lonza's CEO to leave
September 24, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
September 18, 2023 | finance.yahoo.com
Lonza CEO Pierre-Alain Ruffieux to Leave
September 13, 2023 | finance.yahoo.com
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products
August 11, 2023 | finance.yahoo.com
Is Lonza Group AG (VTX:LONN) Worth CHF498 Based On Its Intrinsic Value?
August 2, 2023 | msn.com
Lonza Group AG - ADR (LZAGY) Price Target Increased by 19.33% to 201.84
July 27, 2023 | finance.yahoo.com
Lonza Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
September 24, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
July 25, 2023 | msn.com
Lonza Group: Painful Cut In Guidance, Still A Buy
July 23, 2023 | finance.yahoo.com
LZAGY - Lonza Group AG
July 21, 2023 | msn.com
Lonza Group AG GAAP EPS of CHF5.54, revenue of CHF3.07B
July 21, 2023 | markets.businessinsider.com
Lonza H1 Profit Declines, Underlying Sales Growth At 10% In CER; Updates 2023 Outlook
July 21, 2023 | finance.yahoo.com
UPDATE 1-European shares flat as energy firms counter tech, healthcare drag
June 22, 2023 | finance.yahoo.com
Q4 2023 Avid Bioservices Inc Earnings Call
June 20, 2023 | bizjournals.com
Swiss biotech Lonza Group AG appears to have pulled away from new Emeryville lease
June 5, 2023 | finance.yahoo.com
Is Lonza Group AG's (VTX:LONN) Recent Performance Tethered To Its Attractive Financial Prospects?
May 19, 2023 | finance.yahoo.com
Individual investors account for 56% of Lonza Group AG's (VTX:LONN) ownership, while institutions account for 44%
May 5, 2023 | markets.businessinsider.com
Lonza Announces Results of the 2023 Annual General Meeting All Motions Proposed by Board of Directors Accepted
May 2, 2023 | finance.yahoo.com
Does Lonza Group (VTX:LONN) Deserve A Spot On Your Watchlist?
April 22, 2023 | uk.investing.com
Lonza Group AG (LONNE)
April 22, 2023 | msn.com
DAY BY DAY Upgrades Lonza Group (SIX:LONN)
April 20, 2023 | markets.businessinsider.com
Lonza Increases Straight Bond by CHF 150 Million
April 11, 2023 | finance.yahoo.com
Lonza Group's (VTX:LONN) five-year earnings growth trails the impressive shareholder returns
March 17, 2023 | forbes.com
Lonza Group
February 20, 2023 | investing.com
Citi Reiterates Buy Rating on Lonza Group AG
February 16, 2023 | finance.yahoo.com
The Petri Dish: Blueprint hit with clinical hold, Moderna to set up patient assistance program
See More Headlines
Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Company Calendar

Today
9/24/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Tobacco products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:LZAGY
CUSIP
N/A
CIK
1446711
Web
www.lonza.com
Phone
(161) 316-8111
Fax
41-61-316-9111
Employees
16,218
Year Founded
1897

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
1.86
Quick Ratio
1.27

Sales & Book Value

Annual Sales
$6.52 billion
Price / Sales
5.33
Cash Flow
$1.44 per share
Price / Cash Flow
32.53
Book Value
$15.01 per share
Price / Book
3.11

Miscellaneous

Outstanding Shares
744,690,000
Free Float
744,167,000
Market Cap
$34.77 billion
Optionable
Not Optionable
Beta
0.90

Social Links

(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Pierre-Alain Ruffieux Ph.D. (Age 54)
    Chief Exec. Officer
    Comp: $2.46M
  • Mr. Philippe Deecke (Age 51)
    Chief Financial Officer
  • Ms. Maria Soler Nunez (Age 54)
    Head of Group Operations
  • Mr. Dirk Oehlers
    VP of Investor Relations
  • Mr. Andreas Bohrer
    Group Gen. Counsel & Company Sec.
  • Ms. Victoria Morgan
    Head of External Communications
  • Ms. Jennifer Clancy
    Sr. Director of Global Marketing
  • Dr. Matthias Hofmann
    Head of Corp. Environment, Health, Safety & Global Sustainability
  • Mr. Jean-Christophe Hyvert (Age 51)
    Pres of Biologics Division
  • Ms. Aurelie Dalbiez (Age 46)
    Head of Strategic HR Projects

Key Competitors

View All Competitors













LZAGY Stock - Frequently Asked Questions

Should I buy or sell Lonza Group stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" LZAGY shares.
View LZAGY analyst ratings or view top-rated stocks.

How have LZAGY shares performed in 2023?

Lonza Group's stock was trading at $48.75 at the beginning of the year. Since then, LZAGY stock has decreased by 4.2% and is now trading at $46.69.
View the best growth stocks for 2023 here.

Are investors shorting Lonza Group?

Lonza Group saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 13,700 shares, an increase of 55.7% from the August 15th total of 8,800 shares. Based on an average trading volume of 130,100 shares, the short-interest ratio is currently 0.1 days.
View Lonza Group's Short Interest.

How often does Lonza Group pay dividends? What is the dividend yield for Lonza Group?

Lonza Group declared a dividend on Thursday, May 4th. Investors of record on Wednesday, May 10th will be given a dividend of $0.108 per share on Friday, May 26th. This represents a dividend yield of 0.17%. The ex-dividend date of this dividend is Tuesday, May 9th. This is a positive change from the stock's previous dividend of $0.09.
Read our dividend analysis for LZAGY.

Is Lonza Group a good dividend stock?

Lonza Group (OTCMKTS:LZAGY) pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.19%.
Read our dividend analysis for LZAGY.

What is Lonza Group's stock symbol?

Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."

How do I buy shares of Lonza Group?

Shares of LZAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lonza Group's stock price today?

One share of LZAGY stock can currently be purchased for approximately $46.69.

How much money does Lonza Group make?

Lonza Group (OTCMKTS:LZAGY) has a market capitalization of $34.77 billion and generates $6.52 billion in revenue each year.

How many employees does Lonza Group have?

The company employs 16,218 workers across the globe.

Does Lonza Group have any subsidiaries?
The following companies are subsidiares of Lonza Group: Arch Acquisition LLC, Arch Chemicals Canada Inc., Arch Chemicals Inc., Arch Chemicals Limited, Arch Chemicals Receivables LLC, Arch Chemicals SAS, Arch Personal Care Products L.P., Arch Protection Chemicals Private Limited, Arch Quimica Argentina S.R.L., Arch Quimica Brasil Ltda., Arch Timber Protection B.V., Arch Treatment Technologies Inc., Arch UK Biocides Limited, Arch Water Products France S.A.S., Arch Water Products South Africa (Pty) Ltd, Arch Wood Protection (Aust) Pty Ltd, Arch Wood Protection (M) Sdn. Bhd., Arch Wood Protection (NZ) Limited, Arch Wood Protection (SA) Pty Ltd, Arch Wood Protection Canada Corp., Arch Wood Protection Inc, Bend Research Inc., BioAtrium AG, CH Capsules Malaysia SDN BHD, Capsugel, Capsugel (Thailand) Co. Ltd, Capsugel Australia Pty Ltd, Capsugel Belgium NV, Capsugel Brasil Importação e Distribuição de Insumos Farmacêuticos e Alimentos Ltda., Capsugel Canada Corp., Capsugel Distribucion S. de R.L. de C.V., Capsugel FinanceCo II S.à r.l., Capsugel FinanceCo S.C.A., Capsugel FinanceCo S.à r.l, Capsugel France Holdings SAS, Capsugel France SAS, Capsugel Funding LLC, Capsugel Germany GmbH, Capsugel Healthcare Private Limited, Capsugel Holdings (Hong Kong) Limited, Capsugel Holdings S.à r.l., Capsugel Holdings US Inc., Capsugel Hungary Kft, Capsugel Inc., Capsugel Italy S.R.L., Capsugel Japan Inc., Capsugel Manufacturing Inc., Capsugel Middle East Sàrl, Capsugel New Zealand Limited, Capsugel Pharmaceutical and Health Products Marketing Ltd, Capsugel Philippines Inc., Capsugel Ploermel SAS, Capsugel S.à r.l., Capsugel Spain S.L., Capsugel US LLC, Capsugel de México S. de R.L. de C.V., Diacon Technologies, Diacon Technologies Limited, Hickson Ltd, InterHealth Nutraceuticals, InterHealth Nutraceuticals Incorporated, LLC Capsugel, Lonza (China) Investments Co. Ltd., Lonza AG, Lonza America Inc., Lonza Argentina S.A, Lonza Biologics Inc., Lonza Biologics Porriño S.L., Lonza Biologics Tuas Pte. Ltd, Lonza Biologics plc, Lonza Bioscience SARL, Lonza Bioscience Singapore Pte Ltd, Lonza Biotec s.r.o., Lonza Cologne GmbH, Lonza Colombia S.A.S, Lonza Copenhagen ApS, Lonza Costa Rica S.A., Lonza Geleen B.V., Lonza Guangzhou Ltd, Lonza Guangzhou Nansha Ltd, Lonza Houston Inc., Lonza Inc., Lonza India Private Limited, Lonza Israel Ltd, Lonza Japan Ltd, Lonza Luxembourg S.à r.l., Lonza Microbial Control Asia Pacific Pte Ltd, Lonza Milano S.r.l., Lonza NZ Limited, Lonza Nanjing Ltd, Lonza Netherlands B.V, Lonza Rockland Inc., Lonza Sales AG, Lonza Shanghai International Trading Ltd, Lonza Suzhou Ltd, Lonza Swiss Finanz AG, Lonza Swiss Licences AG, Lonza Verviers SPRL, Lonza Walkersville Inc., Lonza do Brasil Especialidades Quimicas Ltda., MW Encap (Holdings) Limited, MW Encap Limited, Micro-Macinazione, Micro-Macinazione SA, Octane Biotech, Octane Biotech Inc, P.T. Capsugel Indonesia, PharmaCell, Powdersize LLC, Suzhou Capsugel Limited (JV), Triangle Research Labs, Xcelience Clinical Services Ltd, Xcelience LLC, and Zelam Holdings.
Read More
How can I contact Lonza Group?

Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The official website for the company is www.lonza.com. The company can be reached via phone at (161) 316-8111, via email at investor.relations@lonza.com, or via fax at 41-61-316-9111.

This page (OTCMKTS:LZAGY) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -